CLINICAL TRIALS PROFILE FOR ROCKLATAN
✉ Email this page to a colleague
All Clinical Trials for ROCKLATAN
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT05283395 ↗ | Rocklatan® Evaluation | Not yet recruiting | Aerie Pharmaceuticals | Phase 4 | 2022-04-01 | The objective of this study is to evaluate whether the IOP lowering with Rocklatan® is similar, or demonstrates additional IOP lowering, in subjects on a current regimen of latanoprost alone or latanoprost plus addition of either one or two individual agents/bottles with another mechanism of action. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ROCKLATAN
Condition Name
Clinical Trial Locations for ROCKLATAN
Trials by Country
Clinical Trial Progress for ROCKLATAN
Clinical Trial Phase
Clinical Trial Sponsors for ROCKLATAN
Sponsor Name